These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37101085)

  • 1. The Effect of Sampling Cannula on In Vitro Dissolution Testing with USP Paddle Method.
    Gao Z; Smith A
    AAPS J; 2023 Apr; 25(3):46. PubMed ID: 37101085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
    Qureshi SA; McGilveray IJ
    Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
    Zhang Y; Bredael G; Armenante PM
    J Pharm Sci; 2013 Aug; 102(8):2718-29. PubMed ID: 23861178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the impact of media viscosity on dissolution of a highly water soluble drug within a USP 2 mini vessel dissolution apparatus using an optical planar induced fluorescence (PLIF) method.
    Stamatopoulos K; Batchelor HK; Alberini F; Ramsay J; Simmons MJH
    Int J Pharm; 2015 Nov; 495(1):362-373. PubMed ID: 26363111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Approach for the Application of USP Apparatus 3 in Dissolution Tests: Case Studies of Three Antihypertensive Immediate-Release Tablets.
    Espíndola B; Bortolon FF; Pinto JMO; Pezzini BR; Stulzer HK
    AAPS PharmSciTech; 2018 Oct; 19(7):2866-2874. PubMed ID: 29934804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved drug dissolution and product characterization using a crescent-shaped spindle.
    Qureshi SA
    J Pharm Pharmacol; 2004 Sep; 56(9):1135-41. PubMed ID: 15324482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated sampling of in vitro dissolution medium: effect of sampling probes on dissolution rate of prednisone tablets.
    Savage TS; Wells CE
    J Pharm Sci; 1982 Jun; 71(6):670-3. PubMed ID: 7097531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Drug Release from Manipulated Abuse Deterrent Formulations.
    Feng X; Zidan A; Kamal NS; Xu X; Sun D; Walenga R; Boyce H; Cruz CN; Ashraf M
    AAPS PharmSciTech; 2020 Jan; 21(2):40. PubMed ID: 31897805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of variability in dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Smith AP; Doub WH; Westenberger BJ
    J Pharm Sci; 2007 Jul; 96(7):1794-801. PubMed ID: 17252609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.
    Wang Y; Armenante PM
    J Pharm Sci; 2012 Feb; 101(2):746-60. PubMed ID: 22083630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause of high variability in drug dissolution testing and its impact on setting tolerances.
    Qureshi SA; Shabnam J
    Eur J Pharm Sci; 2001 Jan; 12(3):271-6. PubMed ID: 11113646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A better dissolution method for ranitidine tablets USP.
    Cappola ML
    Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibration effects on dissolution tests with USP apparatuses 1 and 2.
    Gao Z; Moore TW; Doub WH
    J Pharm Sci; 2008 Aug; 97(8):3335-43. PubMed ID: 18000813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Media Flow and Tablet Position as Factors of How Air Bubbles Affect Dissolution of Disintegrating and Non-disintegrating Tablets Using a USP 4 Flow-Through Cell Apparatus.
    Yoshida H; Teruya K; Abe Y; Furuishi T; Fukuzawa K; Yonemochi E; Izutsu KI
    AAPS PharmSciTech; 2021 Aug; 22(7):227. PubMed ID: 34431011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study.
    Mann J; Dressman J; Rosenblatt K; Ashworth L; Muenster U; Frank K; Hutchins P; Williams J; Klumpp L; Wielockx K; Berben P; Augustijns P; Holm R; Hofmann M; Patel S; Beato S; Ojala K; Tomaszewska I; Bruel JL; Butler J
    Mol Pharm; 2017 Dec; 14(12):4192-4201. PubMed ID: 28737403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution.
    Röst M; Quist PO
    J Pharm Biomed Anal; 2003 Apr; 31(6):1129-43. PubMed ID: 12667929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
    McCarthy CA; Faisal W; O'Shea JP; Murphy C; Ahern RJ; Ryan KB; Griffin BT; Crean AM
    J Control Release; 2017 Mar; 250():86-95. PubMed ID: 28132935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The random vibration effects on dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Buhse LF; Doub WH
    J Pharm Sci; 2009 Jan; 98(1):297-306. PubMed ID: 18399543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.